Trifluoromethanesulfonamide

Trifluoromethanesulfonamide

SCHEMBL4457467

CCC(C)C(C)(C)N.NS(=O)(=O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA13 Q8N1Q1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL10660732 0.86 TP53 (0.31)
Trifluoromethanesulfonamide SCHEMBL6438309 0.81 CA2 (0.39) CA1CA2CA7CA13
Trifluoromethanesulfonamide SCHEMBL4359432 0.80 CA1 (0.58) CA1CA2CA7CA13
SCHEMBL231913 0.79
SCHEMBL18831873 0.79
Trifluoromethanesulfonamide SCHEMBL6436449 0.78 EPHX1 (0.42) CA1CA2CA7CA13
Water SCHEMBL919837 0.77
Ammonia Solution, Strong SCHEMBL28393676 0.77
Hydrochloric Acid SCHEMBL1201246 0.77
Iodide SCHEMBL1201232 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452425-B2 Compositions containing ionic liquids and their uses, in particular in organic synthesis CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-09-27 US disclosed
US-20090326228-A1 COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-12-31 US disclosed
US-20060128996-A1 Compositions containing Ionic liquids and uses thereof, especially in organic synthesis UNIVERSITE DE RENNES 1 (FR) 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128996-A1 Compositions containing Ionic liquids and uses thereof, especially in organic synthesis F12, ANXA1, OLA1 CA1 78/4885CA2 182/4885CA7 656/4885
US-20090326228-A1 COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS F12, ANXA1, F11 CA1 79/4885CA2 209/4885CA7 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.